St Mary's Center For Rehabilitation & Healthcare | |
210 St Mary's Drive, Cherry Hill, New Jersey 08003 | |
(856) 874-5300 | |
Name | St Mary's Center For Rehabilitation & Healthcare |
---|---|
Location | 210 St Mary's Drive, Cherry Hill, New Jersey |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 215 |
Occupancy Rate | 63.81% |
Medicare ID (CCN) | 315060 |
Legal Business Name | Cherry Hill Operating Llc |
Ownership Type | For Profit - Corporation |
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
The report reflects new medications that have emerged and updates treatment recommendations for pregnant women with asthma based on a systematic review of data on the safety of asthma medications during pregnancy. An executive summary ("Quick Reference") of the guidelines is published in the January issue of the Journal of Allergy & Clinical Immunology.
Elsevier, a world-leading provider of scientific, technical and medical information products and solutions, is pleased to announce the launch of the official journal of the Association for Contextual Behavioral Science, the Journal of Contextual Behavioral Science (JCBS).
Using CRISPR/Cas9 and human intestinal organoids to study genes implicated in the biology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), researchers from the Netherlands identified a specific serine protease (TMPRSS2) as an attractive pan-coronavirus therapeutic target. Their exciting findings are available in a study currently available on the bioRxiv* preprint server.
Patients are emerging as an increasingly strong group when it comes to influencing the success and failure of new drugs - according to a newly published New Health Report commissioned by Quintiles to gauge the opinions of biopharma executives, managed care executives and patients, and to track progress in the New Health.
iCAD, Inc., an industry-leading provider of advanced image analysis and workflow solutions for the early detection of cancer, today announced the launch of an MRI product suite for breast, prostate, and other organs. The product suite, which is a comprehensive quantitative image analysis solution, brings together the company's current products SpectraLook® and VividLook® with the new OmniLook™ and VersaVue™ Enterprise, to offer a comprehensive quantitative image analysis suite.
› Verified 8 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 17.38 | 14.46 |
Percentage of long-stay residents who lose too much weight | 7.79 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 52.31 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.8 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.14 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 2.86 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0.71 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 3.19 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.12 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 9.06 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 81.09 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 1.52 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 30.02 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 15.61 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 6.29 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.42 | 95.98 |
Percentage of short-stay residents who made improvements in function | 62.74 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 87.92 | 82.93 |
News Archive
The report reflects new medications that have emerged and updates treatment recommendations for pregnant women with asthma based on a systematic review of data on the safety of asthma medications during pregnancy. An executive summary ("Quick Reference") of the guidelines is published in the January issue of the Journal of Allergy & Clinical Immunology.
Elsevier, a world-leading provider of scientific, technical and medical information products and solutions, is pleased to announce the launch of the official journal of the Association for Contextual Behavioral Science, the Journal of Contextual Behavioral Science (JCBS).
Using CRISPR/Cas9 and human intestinal organoids to study genes implicated in the biology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), researchers from the Netherlands identified a specific serine protease (TMPRSS2) as an attractive pan-coronavirus therapeutic target. Their exciting findings are available in a study currently available on the bioRxiv* preprint server.
Patients are emerging as an increasingly strong group when it comes to influencing the success and failure of new drugs - according to a newly published New Health Report commissioned by Quintiles to gauge the opinions of biopharma executives, managed care executives and patients, and to track progress in the New Health.
iCAD, Inc., an industry-leading provider of advanced image analysis and workflow solutions for the early detection of cancer, today announced the launch of an MRI product suite for breast, prostate, and other organs. The product suite, which is a comprehensive quantitative image analysis solution, brings together the company's current products SpectraLook® and VividLook® with the new OmniLook™ and VersaVue™ Enterprise, to offer a comprehensive quantitative image analysis suite.
› Verified 8 days ago
Barclays Rehabilitation And Healthcare Center Location: 1412 Marlton Pike, Cherry Hill, New Jersey 08034 Phone: (856) 428-6100 | |
St Mary's Center For Rehabilitation & Healthcare Location: 210 St Mary's Drive, Cherry Hill, New Jersey 08003 Phone: (856) 874-5300 | |
Avista Healthcare Location: 3025 Chapel Avenue West, Cherry Hill, New Jersey 08002 Phone: (856) 675-3000 | |
Premier Cadbury Of Cherry Hill Location: 2150 Route 38, Cherry Hill, New Jersey 08002 Phone: (856) 667-4550 | |
Aristacare At Cherry Hill Location: 1399 Chapel Ave West, Cherry Hill, New Jersey 08002 Phone: (856) 663-9009 | |
Silver Healthcare Center Location: 1417 Brace Road, Cherry Hill, New Jersey 08034 Phone: (856) 795-3131 |